Search Results 111-120 of 16656 for pv
Abnormal vaginal bleeding · Black or bloody stools · Bloating, constipation or diarrhea · Bumps, blisters or open sores · Change in vaginal discharge · Excessive ...
... PV/ET MF) who have not yet received treatment with a Janus kinase inhibitor (JAK inhibitor). Participants will be randomized to receive either MMB or ...
... PV/ET MF) enrolled in Gilead sponsored studies GS-US-352-0101 (NCT01969838), GS-352-1214 (NCT02101268), GS-US-352-1154 (NCT02124746), who are currently ...
It's a treatment for kidney failure, a condition where the kidneys can't filter blood well enough any longer. During peritoneal dialysis, a cleansing fluid ...
The purpose of this study is to estimate the effectiveness of Canakinumab treatment in patients with primary myelofibrosis (PMF), post PV-MF (Post ...
Inclusion Criteria for Randomized Period: * PMF, post-PV MF, or post-ET MF that is TP53WT as assessed by central testing * ECOG performance status of 0 to 2 * ...
Patients must have intermediate-2 or higher primary myelofibrosis (PMF), post-essential thrombocythemia or polycythemia-vera related MF (Post ET/PV MF).
First trimester · Tell your healthcare professional at your next prenatal visit if you have spotting or light vaginal bleeding that goes away within a day.
The objective of this proposal is to assess blood-plasma volume (TBV-PV) status quantitatively in patients with DHF admitted to hospital for volume ...
Kraus MB, Thomson HM, Dexter F, Patel PV, Dodd SE, Girardo ME, Hertzberg LB, Pearson ACS. Pregnancy and Motherhood for Trainees in Anesthesiology: A Survey ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.